Side-by-side comparison of AI visibility scores, market position, and capabilities
London-based virtual business phone number app for employee personal devices; $2.82M YC-backed at $1.4M revenue competing with RingCentral and Dialpad for UK SMB BYOD business communications.
Devyce is a London-based business mobile communications company that provides employees with a virtual UK or international business phone number delivered as an app on their personal smartphone — eliminating the need for companies to provision separate corporate SIM cards or physical devices while maintaining a professional business line separate from personal calls. Founded in 2020 and backed by Y Combinator and Garage Capital with $2.82 million in funding, Devyce generated $1.4 million in revenue in 2024 with a 22-person team, offering instant number provisioning at approximately £15-20 per user monthly.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.